Because perimenopause and menopause cause hormonal changes like weight gain and metabolic changes, Tirzepatide may be a helpful option
The oral GLP-1 component is becoming commercially important as it allows combining the promise of efficacy generated by injectable GLP-1 drugs with the convenience of the oral route of administration
May 16 : Roche's Phase 1 success for the GLP-1/GIP agonist CT-388, which is expected to be combined with GYM329 (RO7204239), a humanized anti-myostatin antibody
Self-management domains cover emotions, cognitions, behaviors, sleep, and environment, with strategies like mindfulness, pleasant activities, social support, and behavioral sleep techniques (67, 68, 83)
Based on research on rodents, semaglutide may cause thyroid C-cell cancers, but it's still not clear how this applies to humans
In some cases insurance will cover the treatments